Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Low-serum GTA-446 anti-inflammatory fatty acid levels as a new risk factor for colon cancer.

Ritchie SA, Tonita J, Alvi R, Lehotay D, Elshoni H, Myat S, McHattie J, Goodenowe DB.

Int J Cancer. 2013 Jan 15;132(2):355-62. doi: 10.1002/ijc.27673. Epub 2012 Jun 26.

PMID:
22696299
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age.

Ritchie SA, Heath D, Yamazaki Y, Grimmalt B, Kavianpour A, Krenitsky K, Elshoni H, Takemasa I, Miyake M, Sekimoto M, Monden M, Tomonaga T, Matsubara H, Sogawa K, Matsushita K, Nomura F, Goodenowe DB.

BMC Gastroenterol. 2010 Nov 29;10:140. doi: 10.1186/1471-230X-10-140.

PMID:
21114854
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study.

Manser CN, Bachmann LM, Brunner J, Hunold F, Bauerfeind P, Marbet UA.

Gastrointest Endosc. 2012 Jul;76(1):110-7. doi: 10.1016/j.gie.2012.02.040. Epub 2012 Apr 11.

PMID:
22498179
[PubMed - indexed for MEDLINE]
4.

Serum gastrin is not higher in subjects with colonic neoplasia.

Kikendall JW, Glass AR, Sobin LH, Bowen PE.

Am J Gastroenterol. 1992 Oct;87(10):1394-7.

PMID:
1415093
[PubMed - indexed for MEDLINE]
5.

Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB.

BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.

PMID:
20156336
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.

Leman ES, Schoen RE, Weissfeld JL, Cannon GW, Sokoll LJ, Chan DW, Getzenberg RH.

Cancer Res. 2007 Jun 15;67(12):5600-5. Retraction in: Schoen RE, Weissfeld JL, Sokoll LJ, Chan DW, Cannon GW, Getzenberg RH. Cancer Res. 2013 Jan 15;73(2):1034.

PMID:
17575123
[PubMed - indexed for MEDLINE]
Free Article
7.

Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study.

Lee JH, Hong SP, Jeon TJ, Kang GH, Choi WC, Jeon SM, Moon CM, Park JJ, Cheon JH, Kim TI, Kim WH.

Dig Dis Sci. 2011 Aug;56(8):2396-403. doi: 10.1007/s10620-011-1606-1. Epub 2011 Feb 17.

PMID:
21327920
[PubMed - indexed for MEDLINE]
8.

Relation between the frequency of colorectal adenoma and the serum cholesterol level.

Mannes GA, Maier A, Thieme C, Wiebecke B, Paumgartner G.

N Engl J Med. 1986 Dec 25;315(26):1634-8.

PMID:
3785334
[PubMed - indexed for MEDLINE]
9.

A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study.

Parente F, Marino B, Ilardo A, Fracasso P, Zullo A, Hassan C, Moretti R, Cremaschini M, Ardizzoia A, Saracino I, Perna F, Vaira D.

Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1145-52. doi: 10.1097/MEG.0b013e328355cc79.

PMID:
22735608
[PubMed - indexed for MEDLINE]
10.

Body iron stores and risk of colonic neoplasia.

Nelson RL, Davis FG, Sutter E, Sobin LH, Kikendall JW, Bowen P.

J Natl Cancer Inst. 1994 Mar 16;86(6):455-60.

PMID:
8120921
[PubMed - indexed for MEDLINE]
11.

Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.

De Chiara L, Rodríguez-Piñeiro AM, Rodríguez-Berrocal FJ, Cordero OJ, Martínez-Ares D, Páez de la Cadena M.

BMC Cancer. 2010 Jun 28;10:333. doi: 10.1186/1471-2407-10-333.

PMID:
20584285
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years.

Strul H, Kariv R, Leshno M, Halak A, Jakubowicz M, Santo M, Umansky M, Shirin H, Degani Y, Revivo M, Halpern Z, Arber N.

Am J Gastroenterol. 2006 Feb;101(2):255-62.

PMID:
16454827
[PubMed - indexed for MEDLINE]
13.

Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study.

Leung K, Pinsky P, Laiyemo AO, Lanza E, Schatzkin A, Schoen RE.

Gastrointest Endosc. 2010 Jan;71(1):111-7. doi: 10.1016/j.gie.2009.05.010. Epub 2009 Jul 31.

PMID:
19647250
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.

Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F.

Gastroenterology. 2012 Aug;143(2):382-9. doi: 10.1053/j.gastro.2012.04.054. Epub 2012 May 15.

PMID:
22609382
[PubMed - indexed for MEDLINE]
15.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

PMID:
20594533
[PubMed - indexed for MEDLINE]
Free Article
16.

Colorectal cancer in patients under close colonoscopic surveillance.

Robertson DJ, Greenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW, Burke CA, Snover DC, Bresalier RS, McKeown-Eyssen G, Mandel JS, Bond JH, Van Stolk RU, Summers RW, Rothstein R, Church TR, Cole BF, Byers T, Mott L, Baron JA.

Gastroenterology. 2005 Jul;129(1):34-41.

PMID:
16012932
[PubMed - indexed for MEDLINE]
17.

Clinical predictors of colorectal polyps and carcinoma in a low prevalence region: results of a colonoscopy based study.

Bafandeh Y, Khoshbaten M, Eftekhar Sadat AT, Farhang S.

World J Gastroenterol. 2008 Mar 14;14(10):1534-8.

PMID:
18330943
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?

Brown DA, Hance KW, Rogers CJ, Sansbury LB, Albert PS, Murphy G, Laiyemo AO, Wang Z, Cross AJ, Schatzkin A, Danta M, Srasuebkul P, Amin J, Law M, Breit SN, Lanza E.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):337-46. doi: 10.1158/1055-9965.EPI-11-0786. Epub 2011 Dec 5.

PMID:
22144502
[PubMed - indexed for MEDLINE]
Free Article
19.

Protection from colorectal cancer after colonoscopy: a population-based, case-control study.

Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M.

Ann Intern Med. 2011 Jan 4;154(1):22-30. doi: 10.7326/0003-4819-154-1-201101040-00004.

PMID:
21200035
[PubMed - indexed for MEDLINE]
20.

Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.

Chan AT, Ogino S, Giovannucci EL, Fuchs CS.

Gastroenterology. 2011 Mar;140(3):799-808, quiz e11. doi: 10.1053/j.gastro.2010.11.041. Epub 2010 Nov 27.

PMID:
21115010
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk